Stocks · Health care · Pharmaceutical Preparations

GALECTIN THERAPEUTICS INC

GALT Clue Score21
United States Fiscal year ends December CIK 0001133416 Results filed 14 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
10X Fund, L.P.
16 Dec 2025
10% owner
Sell
30,681
$6.66
$204.34K
10X Fund, L.P.
3 Dec 2025
10% owner
Sell
120,000
$5.73
$687.60K
10X Fund, L.P.
2 Dec 2025
10% owner
Sell
30,000
$5.47
$164.10K
10X Fund, L.P.
11 Nov 2025
10% owner
Sell
40,000
$5.25
$210.00K

What was left out

Form 4 filings counted 43
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 43
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 35,181,445
History held since 9 Feb 2007